Bio-Rad Laboratories, Inc. (NYSE:BIO) is one of the best debt-free mid-cap stocks to buy according to hedge funds. On February 12, Bio-Rad Laboratories, Inc. (NYSE:BIO) delivered solid fourth-quarter ...
Bio-Rad Laboratories, Inc. BIO posted fourth-quarter 2025 adjusted earnings per share (EPS) of $2.51, which missed the Zacks Consensus Estimate by 2.3%. The bottom line decreased 13.4% from the ...
All Rad Web Hosting VPS plans listed on VPSBenchmarks are tested using objective performance measurements rather than vendor-supplied data. These tests simulate real usage scenarios relevant to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results